🔎 Trials Near Me

Akèy › Leukemi › New Jersey › Clifton

Etid klinik pou Leukemi nan Clifton, NJ

7 etid pou Leukemi ap chèche patisipan nan sit nan ak bò kote Clifton (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

Ap rekriteFaz 2
  • John Theurer Cancer Center at Hackensack UMC, Hackensack · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT06824168

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Ap rekriteFaz 1
  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT06001788

Mosaic Trial for Stem Cell Transplant Recipients

Ap rekrite
  • Hackensack Meridian Health, Nutley · 3 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT06960993

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Ap rekriteFaz 2
  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07216443

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Ap rekriteEtid obsèvasyon
  • Hackensack University Medical Center, Hackensack · 7 mi lwen
Tout laj · Tout sèks · Mizajou May 18, 2026 · NCT01790152

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Ap rekriteFaz 2/3
  • John Theurer Cancer Center / Hackensack University, Hackensack · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT04256317

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Ap rekriteFaz 1
  • Hackensack University Medical Center, Hackensack · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Mar 13, 2026 · NCT05735184

Etid Leukemi nan lòt vil

Lòt etid nan Clifton

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.